Related Experiment Videos
Transfer factor treatment in bullous pemphigoid. Impaired T cell function
Dermatologica
|January 1, 1980
Summary
Transfer factor (TF) therapy improved cellular immunity in a bullous pemphigoid patient unresponsive to prednisone. This immune enhancement led to sustained remission of skin lesions and normalized T cell function.
Area of Science:
- Immunology
- Dermatology
- Cellular Immunity
Background:
- Bullous pemphigoid (BP) is an autoimmune blistering skin disease.
- Some BP patients exhibit impaired cellular immunity and may not respond to standard treatments like prednisone.
- Cellular immunity, particularly T cell function, plays a role in the pathogenesis of BP.